Leqvio 284 MG/1.5 ML syringe 1.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F5W4B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,813
Award facts
- Contract value 100% obligated
- $24,812.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 30, 2026, the Defense Logistics Agency awarded a delivery order valued at $24,812.70 to AmerisourceBergen Drug Corp for the supply of Leqvio 284 mg/1.5 mL syringes. This firm fixed-price, non-set-aside contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of February 23, 2026. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement through its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and related military healthcare systems. The company's federal contract awards demonstrate consistent capability in fulfilling diverse medical supply needs across multiple therapeutic domains, competing successfully on a full and open basis without set-aside designations. This delivery order for Leqvio, a PCSK9 inhibitor used in cardiovascular treatment, exemplifies the company's role in supplying specialty medications essential to military treatment facilities and federal healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F5W4B?
SPE2DR26F5W4B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F5W4B worth?
The government has obligated $24,813 on SPE2DR26F5W4B.
Is contract SPE2DR26F5W4B an order under another contract?
Yes. SPE2DR26F5W4B is a delivery order under SPE2DR25D3404, an indefinite delivery contract.
Was contract SPE2DR26F5W4B competed?
The extent of competition for SPE2DR26F5W4B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award